Skip to content

Company profile · 3 min read

Prana: continuous AI-assisted primary care

Prana connects medical records and wearables to continuous AI monitoring, with human doctor visits available for escalation and care.

What it does

Prana is building an always-on primary-care service that connects medical records and wearables, watches for “clinical drift,” explains labs and routes care to human doctors when needed. The YC profile describes a full-stack medical provider rather than a standalone health chatbot: AI handles history, logistics and triage while physicians focus on higher-leverage decisions.

The fit is a person who wants continuous monitoring between visits and is willing to use a hybrid AI/doctor model. The product is not a replacement for emergency care or a general answer engine. Its value depends on data quality, appropriate escalation and a clear boundary between monitoring, clinical advice and prescription management.

Why I’d look closer

The current homepage is unusually simple about the entry path: chat with the AI doctor for free, or see a real doctor for a flat $39 visit, with no subscription advertised. The FAQ is the source checked for that pricing/access framing. That makes a first test accessible, but it also makes the clinical governance questions more important.

The founder mix is relevant. The YC biographies describe Meer Patel with Johns Hopkins biomedical engineering, Brown medical-school deferral and applied-AI/diagnostics experience; Sanjit Menon as an MD candidate and clinical-operations co-founder; and Vishvam Rawal with quantitative-research and medical-AI systems experience. The profile says Prana is live in beta with early users; that is company-reported early status.

What I’d ask

Which records and wearables are supported, how is “clinical drift” defined, and what triggers a human physician? How are prescriptions, urgent symptoms, false alarms and missing data handled? I’d ask for the clinical protocol, physician review ratio, data retention/BAA terms and a clear emergency disclaimer before relying on the service.

My editorial take

Prana is interesting because it pairs a low-friction AI entry point with human care rather than pretending monitoring is enough. The $39 visit model is easy to understand. The decision should turn on escalation quality and patient safety, not on the always-on metaphor.

Quick facts

FieldSourced detail
Buyer fitConsumers seeking continuous primary-care support
ProductAI monitoring of records/wearables plus human physician visits
Public priceAI chat free; real doctor visit listed at $39; company homepage claim
StatusBeta with early users; company-reported

Sources checked

Checked 2026-09-19.

SourceUsed for
YC company profileProduct, founders and beta context
Prana homepageCurrent access and $39 visit claim
Prana FAQPublic trust/pricing question surface

Cohort context

Prana is listed in Winter 2026. In our 2026-09-18 directory snapshot, 16 of 199 listed companies in that cohort have YC’s primary industry label Healthcare (8.0%). This is a current-directory comparison, not an original intake count or a performance ranking. Nine-cohort dataset.

Public website snapshot

Observed 2026-09-19 16:20 UTC in raw homepage HTML. This records visible metadata and advertised links, not agent execution or product quality.

SignalHomepage observation
Product description metadataObserved
Canonical linkObserved
H1 or H2 headingObserved
Typed structured dataObserved
Docs/developer linkNot observed in this response
Pricing linkNot observed in this response
llms.txt linkObserved
Markdown alternateNot observed in this response

Public observations · Collection method. Missing links here do not establish that a capability or file is absent elsewhere.

Ali Abouelatta

About the author

Cofounder of Lazyweb (a16z Speedrun). Previously grew subscriptions and built native ads at Duolingo. Writes First1000 (90,000+ subscribers).

I cofound Lazyweb, which publishes this site. This is an owner-written publication, not an independent testing organization. Research notes distinguish observations, sourced reporting and editorial judgment.

First1000X